Why Ginkgo Bioworks Stock Is Sinking Today
There was double trouble for this beaten-down biotech stock.
Bull Market and Beyond: 3 Stocks Just Waiting to Soar
These pharma and biotech players could become long-term winners.
Ginkgo Bioworks Stock: Bull vs. Bear
This innovative biotechnology company hopes to turn things around.
Should You Buy the Dip on Ginkgo Bioworks Stock?
Its vision is ambitious, but can it actually be made to work?
2 Cathie Wood Biotech Stocks That Could Be Worth the Risk
You don't need to buy her picks, but it's worth understanding them.
3 Things You Need to Know if You Buy Ginkgo Bioworks Today
It needs to work within the constraints imposed by these three issues.
Down 72%. Is Ginkgo Bioworks a Buy on the Dip?
The number of cell engineering partnerships Ginkgo Bioworks has is way up, but the same can't be said about its stock price.
Ginkgo Bioworks Stock Has 37.5% Downside, According to 1 Wall Street Analyst
Ginkgo Bioworks has become a penny stock -- and that's the least of its problems,
Is Ginkgo Bioworks Holdings Stock a Buy?
Can this struggling stock turn things around?
4 Small-Cap Value Stocks That Could Go Parabolic
These four small-cap stocks scan as deeply undervalued right now.